Lymph node localization of non-specific antibody-coated liposomes

Area of Science:

• Biomedical Engineering
• Nanotechnology
• Immunology

Background:

• Small unilamellar liposomes injected subcutaneously drain into lymphatics and localize in regional lymph nodes.
• This property suggests potential for detecting metastatic breast cancer spread and delivering drugs to affected lymph nodes.
• Antibody-coated liposomes may offer enhanced targeting capabilities for lymph node-related therapies.

Purpose of the Study:

• To investigate the lymph node localization of immunoglobulin G (IgG)-coated liposomes after subcutaneous injection.
• To compare the lymph node uptake of IgG-coated liposomes versus control liposomes.
• To explore factors influencing the localization, such as free IgG and liposome charge.

Main Methods:

• Subcutaneous injection of small unilamellar liposomes labeled with aqueous ([125I]-polyvinylpyrrolidone) and lipid ([3H]-cholesterol) phase markers into mouse and rat footpads.
• Administration of IgG-coated liposomes and control liposomes.
• Assessment of liposome distribution and localization in regional lymph nodes.
• Evaluation of the effect of free IgG and liposome charge on uptake.

Main Results:

• IgG-coated liposomes were rapidly removed from the injection site and showed greater localization in regional lymph nodes compared to control liposomes.
• Free IgG inhibited the uptake of IgG-coated liposomes by lymph nodes.
• Liposome charge significantly influenced the localization of IgG-coated liposomes in regional lymph nodes.

Conclusions:

• Antibody-coated liposomes demonstrate efficient accumulation in regional lymph nodes.
• These findings suggest antibody-coated liposomes are a promising platform for targeted drug delivery to lymph nodes for diseases like breast cancer.
• Such liposomes could also improve the detection of lymph node metastases using lymphoscintigraphic agents.